Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder
Bangshan Liu, Jin Liu, Mi Wang, et al.
Frontiers in Cellular Neuroscience (2017) Vol. 11
Open Access | Times Cited: 221

Showing 1-25 of 221 citing articles:

Gut Microbiota and the Neuroendocrine System
Aitak Farzi, Esther E. Fröhlich, Peter Holzer
Neurotherapeutics (2018) Vol. 15, Iss. 1, pp. 5-22
Open Access | Times Cited: 388
Recognizing Depression from the Microbiota–Gut–Brain Axis
Shan Liang, Xiaoli Wu, Xu Hu, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 6, pp. 1592-1592
Open Access | Times Cited: 324
Air Pollution, Stress, and Allostatic Load: Linking Systemic and Central Nervous System Impacts
Errol M. Thomson
Journal of Alzheimer s Disease (2019) Vol. 69, Iss. 3, pp. 597-614
Open Access | Times Cited: 224
Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications
Alexandria Tartt, Madeline Mariani, René Hen, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 6, pp. 2689-2699
Open Access | Times Cited: 218
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova, Anthony G. Phillips
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 11, pp. 929-942
Closed Access | Times Cited: 161
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Dmitriy Matveychuk, Rejish K. Thomas, Jennifer Swainson, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 160
Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
Thu Ha Pham, Alain M. Gardier
Pharmacology & Therapeutics (2019) Vol. 199, pp. 58-90
Open Access | Times Cited: 154
New Insights into the Pivotal Role of the Amygdala in Inflammation-Related Depression and Anxiety Disorder
Ping Hu, Ying Lü, Bing‐Xing Pan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11076-11076
Open Access | Times Cited: 71
Gut dysbiosis in patients with chronic pain: a systematic review and meta-analysis
Lisa Goudman, Thomas Demuyser, Julie G. Pilitsis, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression
Ningning Guo, Xin Wang, Muran Xu, et al.
Pharmacological Research (2024) Vol. 206, pp. 107300-107300
Open Access | Times Cited: 18
Depressive disorders: Treatment failures and poor prognosis over the last 50 years
Thomas P. Blackburn
Pharmacology Research & Perspectives (2019) Vol. 7, Iss. 3
Open Access | Times Cited: 107
Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study
Kathryn R. Cullen, Palistha Amatya, Mark G. Roback, et al.
Journal of Child and Adolescent Psychopharmacology (2018) Vol. 28, Iss. 7, pp. 437-444
Open Access | Times Cited: 94
Delivery of Oxytocin to the Brain for the Treatment of Autism Spectrum Disorder by Nasal Application
Akiko Tanaka, Tomoyuki Furubayashi, Mari Arai, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 3, pp. 1105-1111
Closed Access | Times Cited: 90
Is There a Role of Autophagy in Depression and Antidepressant Action?
Nils C. Gassen, Theo Rein
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 85
Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments
Kyle T. Greenway, Nicolas Garel, Lisa Jerome, et al.
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 6, pp. 655-670
Closed Access | Times Cited: 71
Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome
Minjia Chen, Guangcong Ruan, Lu Chen, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 66
The molecular pathophysiology of depression and the new therapeutics
Haihua Tian, Zhenyu Hu, Jia Xu, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 64
Targeting neuroinflammation by polyphenols: A promising therapeutic approach against inflammation-associated depression
Mohammed Abu Tayab, Mohammad Nazmul Islam, Kazi Ashfak Ahmed Chowdhury, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112668-112668
Open Access | Times Cited: 62
Multi-Probiotics ameliorate Major depressive disorder and accompanying gastrointestinal syndromes via serotonergic system regulation
Peijun Tian, Renying Zou, Luyao Wang, et al.
Journal of Advanced Research (2022) Vol. 45, pp. 117-125
Open Access | Times Cited: 61
Dysregulation of brain dopamine systems in major depressive disorder
Nella C. Delva, Gregg D. Stanwood
Experimental Biology and Medicine (2021) Vol. 246, Iss. 9, pp. 1084-1093
Open Access | Times Cited: 58
Oral administration ofLactococcus lactisWHH2078 alleviates depressive and anxiety symptoms in mice with induced chronic stress
Kan Gao, Aitak Farzi, Xueqin Ke, et al.
Food & Function (2021) Vol. 13, Iss. 2, pp. 957-969
Closed Access | Times Cited: 55
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32
Immune mechanisms of depression in rheumatoid arthritis
James B. Brock, Neil Basu, Johannes C. M. Schlachetzki, et al.
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 12, pp. 790-804
Closed Access | Times Cited: 30
Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression
Jared M. Kopelman, Timothy A. Keller, Benjamin Panny, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 29
Histone serotonylation in dorsal raphe nucleus contributes to stress- and antidepressant-mediated gene expression and behavior
Amni Al-Kachak, G. Salvo, Sasha L. Fulton, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top